UNC Health Brings Together Best-In-Breed Vendors to Release New Digital Health Features and Further Enhance Patient Experience

Smartlink Integration, Fueled by WELL Health and Gozio Health, Drives 443% Increase in Daily App Downloads CHAPEL HILL, N.C.–(BUSINESS WIRE)–UNC Health, a not-for-profit integrated health care system owned by the state of North Carolina and based in Chapel Hill, announced today that it is releasing new features within its mobile platform. Partnering with industry leaders, … [Read more…]

Chuck Mooty, Minnesota Business Hall of Fame Inductee, Joins Ōmcare Board of Directors

Esteemed business leader, Chuck Mooty, joins the Board of Directors for innovative home health technology. MINNEAPOLIS–(BUSINESS WIRE)–Ōmcare announced that Chuck Mooty has joined their Board of Directors. Recently, Mooty was announced as a 2022 Minnesota Business Hall of Fame inductee for his many successes and thoughtful leadership throughout his career. Within a six-year window, Mooty … [Read more…]

Mirion Technologies Acquires Critical Infrastructure Business of Collins Aerospace

Mirion Technologies acquires Critical Infrastructure business of Collins Aerospace to expand capabilities in software, cybersecurity ATLANTA–(BUSINESS WIRE)–Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), a leading provider of comprehensive systems that detect and monitor radiation in medical, industrial and defense end markets, today announced the acquisition of the Critical Infrastructure (CI) business of Collins Aerospace (through ARINC … [Read more…]

Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use

 The Be The Match Registry® includes more than 266,000 fully characterized CBUs, allowing for therapy-matched unit identification. MINNEAPOLIS–(BUSINESS WIRE)–Be The Match BioTherapies® announced it is now providing cryopreserved Cord Blood Units as allogeneic cell therapy starting material for non-clinical, clinical, and commercial use. The Be The Match Registry®, with more than 266,000 fully-characterized cord blood … [Read more…]

CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors

Mr. Claiborne Joined the CytRx Board of Directors as of the Annual Meeting LOS ANGELES–(BUSINESS WIRE)–CytRx Corporation (OTCQB: CYTR) (“CytRx” or the “Company”), a biopharmaceutical innovator focused on research and development of life-saving cancer therapeutics, welcomes Mr. Cary J. Claiborne to the CytRx Board of Directors (the “Board”). Mr. Claiborne brings to CytRx a wealth … [Read more…]

Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product

Company awarded commercial GMP license following successful EMA inspection of Memphis CDMO facility MEMPHIS, Tenn.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River Laboratories, International Inc. (NYSE: CRL) announced it has received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products for distribution in Europe, from the European Medicines Agency … [Read more…]

2022 International Symposium on Human Identification (ISHI) Keynote DeNeen L. Brown Outlines Search for Victims of 1921 Tulsa Race Massacre

Largest annual global DNA forensics meeting convenes October 31 – November 3 in Washington D.C. MADISON, Wis.–(BUSINESS WIRE)–More than 1000 forensic DNA experts and law enforcement professionals from around the world will gather at the International Symposium on Human Identification (ISHI) October 31 – November 3 in Washington D.C. Keynote speaker DeNeen L. Brown, a … [Read more…]

ADC Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

ZYNLONTA® (loncastuximab tesirine-lpyl) net sales of $17.3 million in the second quarter of 2022 Ex-U.S. ZYNLONTA license agreement with Sobi® facilitates global patient access and extends cash runway into early 2025 Company to host conference call today at 8:30 a.m. EDT LAUSANNE, Switzerland–(BUSINESS WIRE)–ADC Therapeutics SA (NYSE: ADCT) today reported financial results for the second … [Read more…]

Ferring Announces U.S. FDA Advisory Committee Meeting for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic

Vaccines and Related Biological Products Advisory Committee will hold meeting on September 22, 2022 RBX2660 is an investigational microbiota-based live biotherapeutic studied for its potential to reduce recurrent C. difficile infection after antibiotic treatment SAINT-PREX, Switzerland & PARSIPPANY, N.J.–(BUSINESS WIRE)–#FDA–Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the … [Read more…]